Envista Holdings (NVST) Cash & Equivalents (2019 - 2026)
Envista Holdings' (NVST) quarterly Cash & Equivalents came in at $1.1 billion in Q2 2026, up 0.51% year-on-year from $1.1 billion in Q2 2025, and down 10.64% quarter-over-quarter from $1.2 billion in Q4 2025.
Envista Holdings (NVST) Cash & Equivalents (2019 - 2026) Analysis & Trends
Envista Holdings' Cash & Equivalents history runs 8 years deep, the most recent figure standing at $1.1 billion for Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 0.51% year-over-year to $1.1 billion in Q2 2026; TTM through Apr 2026 was $1.1 billion, a 0.51% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 13.34% from the prior year.
- Cash & Equivalents declined to $1.1 billion in Q2 2026 per NVST's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Cash & Equivalents topped out at $1.2 billion in Q4 2025 and bottomed at $523.1 million in Q3 2022.
- The 5-year median for Cash & Equivalents is $991.3 million (2024), against an average of $908.2 million.
- Across the five-year window, Cash & Equivalents jumped 144.4% in 2022 and slumped 45.73% in 2023, its largest moves.
- Year by year, Cash & Equivalents stood at $606.9 million in 2022, then jumped by 54.89% to $940.0 million in 2023, then advanced by 13.73% to $1.1 billion in 2024, then gained by 13.34% to $1.2 billion in 2025, then decreased by 10.64% to $1.1 billion in 2026.
- Per Business Quant, the three latest NVST Cash & Equivalents figures stand at $1.1 billion (Q2 2026), $1.2 billion (Q4 2025), and $1.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 1.58 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 813.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.21 Bn |
| Sep 26, 2025 | 1.13 Bn |
| Jun 27, 2025 | 1.11 Bn |
| Mar 28, 2025 | 1.08 Bn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 27, 2024 | 991.30 Mn |
| Jun 28, 2024 | 1.04 Bn |
| Mar 29, 2024 | 948.50 Mn |
| Dec 31, 2023 | 940.00 Mn |
| Sep 29, 2023 | 824.20 Mn |
| Jun 30, 2023 | 651.70 Mn |
| Mar 31, 2023 | 585.20 Mn |
| Dec 31, 2022 | 606.90 Mn |
| Sep 30, 2022 | 568.50 Mn |
| Jul 1, 2022 | 523.10 Mn |
| Apr 1, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.07 Bn |
| Oct 1, 2021 | 638.80 Mn |
| Jul 2, 2021 | 553.90 Mn |